Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Transfusion Clinique et Biologique is Scopus-indexed (Q3, CiteScore 2.2), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier Masson s.r.l..
Checked against the index lists dated .
ISSN 1246-7820Verify ISSN ↗1953-8022Verify ISSN ↗
Publisher: Elsevier Masson s.r.l.
Cost to publish: About US$1,820 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Hematology | 92 / 151 | 39th | Q3 |
| Biochemistry (medical) | 50 / 78 | 36th | Q3 |
| Clinical Biochemistry | 100 / 124 | 19th | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1994–present, best quartile Q3, CiteScore 2.2.
Transfusion Clinique et Biologique is Q3 in Hematology (rank 92 of 151), Q3 in Biochemistry (medical) (rank 50 of 78) and Q4 in Clinical Biochemistry (rank 100 of 124), by CiteScore 2025.
Transfusion Clinique et Biologique is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.2, which places it in quartile Q3 at the 39th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.341, quartile Q3, with an H-index of 47.
The publisher lists an article processing charge of about US$1,820 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Transfusion Clinique et Biologique is published by Elsevier Masson s.r.l. Its print ISSN is 1246-7820 and its online ISSN is 1953-8022.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Transfusion Clinique et Biologique has an h-index of 53 and a 2-year mean of 0.38 citations per paper (OpenAlex). Its Scopus CiteScore is 2.2, quartile Q3. On 2-year citations it ranks #117 of 148 Scopus journals in Hematology.
Transfusion Clinique et Biologique published 442 papers in 2025; its busiest recent year was 2023 with 448. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 89 research articles (2025–2026), authors are most often from India (39.3%), France (23.6%) and United States (6.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (0.3 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.